CD274 and neoplasm: Additionally, the therapeutic effect of antibody medicines may be negated by compensatory upregulation of PD-L1 within tumor cells, active redistribution of PD-L1 to the cell membrane, and the consumption of antibodies by PD-L1 in tumor exosomes at distant regions of the tumor (11–13).